Balaji Amines reported a consolidated net profit of ₹78 crore for Q1FY27, a 110.19% increase from ₹37 crore in Q1FY26, driven by significant EBITDA margin expansion to 26%. The company’s total revenue rose 25.73% to ₹461 crore from ₹367 crore in the prior year period, demonstrating strong pricing power and operational efficiency despite declining sales volumes. The Board of Directors approved the unaudited financial results on July 27, 2026, and the investor presentation was filed with stock exchanges on July 29, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance

Consolidated revenue from operations increased to ₹456 crore from ₹358 crore in Q1FY26. Consolidated EBITDA rose sharply to ₹121 crore from ₹63 crore, representing a 91.51% year-on-year growth. The EBITDA margin expanded by 900 basis points to 26% from 17% in Q1FY26. Profit before tax grew 118.14% to ₹106 crore. Diluted earnings per share (EPS) increased to ₹23.13 from ₹11.73.

Standalone net profit rose to ₹72 crore from ₹40 crore in Q1FY26. Standalone revenue was ₹429 crore, up from ₹327 crore. Standalone EBITDA margin expanded to 26% from 20%. Cash PAT, defined as PAT plus depreciation and deferred tax, stood at ₹97 crore, up from ₹51 crore.

Volume and Segment Analysis

Total sales volumes declined to 21,587 MT in Q1FY27 from 27,570 MT in Q1FY26, reflecting a strategic shift towards higher-margin products. Amines volumes were 6,248.57 MT, Amines Derivatives volumes were 8,205.11 MT, and Specialty Chemicals volumes contributed 7,132.92 MT. The disproportionate growth in profitability relative to revenue highlights effective product mix optimization.

What the Numbers Show

The divergence between declining volumes and surging profitability underscores a pivot towards high-value specialty chemicals. The 900 basis point expansion in EBITDA margins indicates successful mitigation of input cost pressures through pricing power and operational efficiencies. Core chemical business Return on Capital Employed (ROCE) remained robust at 13% for FY26, compared to 12% in FY25, demonstrating strong fundamentals despite heavy capital expenditure.

New Projects and Expansion

Balaji Amines commissioned its 100,000 TPA Dimethyl Ether (DME) plant, India’s first commercial-scale facility for this product, targeting LPG blending and aerosol propellant markets. The N-Methyl Morpholine (NMM) and Acetonitrile (ACN) capacity expansions are on track for commissioning by end-FY27. Capital work-in-progress totals ₹165.60 crore for these projects.

Subsidiary Balaji Speciality Chemicals Limited (BSCL), which holds Mega Project Status, is executing a phased expansion. Unit-I expansion for EDA-based products is expected in FY27. Greenfield Unit-II at MIDC Chincholi, producing Hydrogen Cyanide (HCN), Sodium Cyanide (NaCN), EDTA, and EDTA-2Na, is targeted for FY27 commissioning. BSCL’s capital work-in-progress stands at ₹401.06 crore. These projects aim to build indigenous capabilities in cyanide chemistry, reducing import reliance for pharmaceutical and agrochemical industries.

Balaji Amines Limited declared a dividend of Rs 11 per equity share for the financial year ended March 31, 2026, at its 38th Annual General Meeting (AGM) held on July 10, 2026. The meeting, conducted via video conference, approved the adoption of audited financial statements and the re-appointment of a director. The dividend declaration provides direct returns to shareholders, marking a key outcome of the company's annual proceedings.

Proceedings of the 38th AGM

The AGM commenced at 12:00 Noon IST and concluded at 12:35 P.M. Mr. Ande Prathap Reddy, Executive Chairman, chaired the meeting attended by 68 members. The company secretary confirmed compliance with the Ministry of Corporate Affairs General Circular dated September 22, 2025, and SEBI Circular dated October 3, 2024. The requisite quorum was present, and the notice convening the meeting was taken as read.

Financial Approvals and Resolutions

Shareholders adopted the Audited Financial Statements, including the Audited Consolidated Financial Statements for FY26. The Auditor's report and the Secretarial Audit Report contained no qualifications. The statutory auditors, M/s. M. Anandam & Co., were present. Four resolutions were passed with the requisite majority.

E-voting and Scrutiny

Remote e-voting was facilitated from July 7, 2026, to July 9, 2026. Mr. Mohit Gurjar, Practising Company Secretary and Partner at M/s. P S Rao & Associates, served as the scrutinizer. The scrutinizer is expected to submit the voting report to the stock exchanges within two working days from the conclusion of the meeting.